SINOVAC BIOTECH LTD Deferred Tax Liabilities, Tax Deferred Income
SINOVAC BIOTECH LTD (SVA) had Deferred Tax Liabilities, Tax Deferred Income of $30.74 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2026-06-05
- 2025-12-31: Deferred Tax Liabilities, Tax Deferred Income $30.74M.
- 2024-12-31: Deferred Tax Liabilities, Tax Deferred Income $84.77M.
- 2023-12-31: Deferred Tax Liabilities, Tax Deferred Income $75.49M.
- 2022-12-31: Deferred Tax Liabilities, Tax Deferred Income $11.10M.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2025-12-31 | $30.74M 20-F · filed 2026-06-05 |
| 2024-12-31 | $84.77M 20-F · filed 2026-06-05 |
| 2023-12-31 | $75.49M 20-F · filed 2026-04-30 |
| 2022-12-31 | $11.10M 20-F · filed 2026-04-30 |
| 2021-12-31 | $3.82M 20-F · filed 2026-04-30 |